News
Stocktwits on MSN26m
AstraZeneca In Talks To License Summit Therapeutics’ Experimental Lung Cancer Drug: ReportAstraZeneca PLC (AZN) and Summit Therapeutics Inc (SMMT) are reportedly discussing a $15 billion partnership to license the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback